2 results
Approved WMORecruiting
The main objective of PD0053 is to provide POC for the efficacy of the ASYN misfolding inhibitor UCB0599 in reducing disease progression in study participants with early-stage PD, and to instruct later stage development. The ultimate goal is to…
Approved WMORecruiting
The main objective of the study is to determine whether low dose amitriptyline (10-20 mg nightly) in chronic insomnia coexisting with medical conditions is as effective as CBT-I in improving subjective sleep. Secondary objectives include (1)…